Tolerance to SARS-CoV-2 mRNA Vaccination in a Patient With Challenge-Confirmed PEG 2000 Allergy

Faihs, V; Bent, R; Darsow, U; Biedermann, T; Brockow, K

Faihs, V; Bent, R; Darsow, U; Biedermann, T; Brockow, K.

Afiliação

Faihs, V; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Bent, R; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Darsow, U; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Biedermann, T; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Brockow, K; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany

J. investig. allergol. clin. immunol ; J. investig. allergol. clin. immunol. (Internet);33(2): 149-150, 2023. tab

Article em En | IBECS | ID: ibc-219425

Biblioteca responsável: ES1.1

Localização: ES15.1 - BNCS

Assuntos

Humanos; Feminino; Idoso; Infecções por Coronavirus/prevenção & controle; Vacinas Virais/administração & dosagem; Polietilenoglicóis/efeitos adversos; Hipersensibilidade a Drogas; RNA Mensageiro

Palavras-chave

SARS-CoV-2; COVID-19; Polyethylene glycol; mRNA vaccine; Anaphylaxis; SARS-CoV-2; COVID-19; Polietilenglicol; Vacuna mRNA; Anafilaxia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

Buscar no Google

Texto completo: 1 Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Polietilenoglicóis / Vacinas Virais / Infecções por Coronavirus / Hipersensibilidade a Drogas Limite: Aged / Female / Humans Idioma: En Revista: J. investig. allergol. clin. immunol / J. investig. allergol. clin. immunol. (Internet) Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

Buscar no Google